ImmunityBio is a California-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $557k
Employees: 501-1,000
Address: 9920 Jefferson Blvd
City: Culver City
State: CA
Zip: 90232
Country: US
ImmunityBio is a California-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and infectious diseases.
Contact Phone:
+18446965235
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/10/2021
Ticker Symbol:
IBRX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2016 | Private Equity Round | $57M | 12/2014 | Venture Round | $10M | 12/2018 | Private Equity Round | $30M | 7/2022 | Post-IPO Equity | $10.7M | 12/2021 | Post-IPO Debt | $300M | 12/2022 | Post-IPO Debt | 1 | $50M |
NantCapital Nant Capital, LLC |
6/2015 | Private Equity Round | 1 | $75M |
Patrick Soon-Shiong Patrick Soon-Shiong Patrick Soon-Shiong Patrick Soon-Shiong |
12/2022 | Post-IPO Equity | $106.6M |
Nant Capital, LLC |
12/2022 | Post-IPO Debt | $50M | 12/2022 | Post-IPO Equity | 1 | $107M |
NantCapital NantCapital |
---|
Announced Date | Name | Price |
---|---|---|
12/2020 | NantKwest | |
6/2017 | Altor BioScience | |
6/2015 | VivaBioCell |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|